Work

Supplementary Table 4 from Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 4

DOI: 10.1158/1940-6207.22534415

Authors: Chelsea Anderson, Hazel B. Nichols, Melissa House, Dale P. Sandler

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362551077

Cites:

Cited by:

Related to: 10